经颅直流电刺激减少边缘型人格障碍冲动性的疗效(TIMBER):随机对照临床试验研究方案
本研究为多中心、交叉、双盲试验,比较主动与伪经颅直流电刺激(2 mA,30分钟)作用于背外侧前额叶皮层连续5天对50例边缘型人格障碍患者的冲动性、抑郁症状和自杀风险的影响。主要疗效指标为脑电图在气球模拟风险任务中检测的特定诱发电位波幅变化,基线测量与干预后即刻、12天及30天后的评分进行比较。
要点
- 多中心交叉双盲设计比较主动与伪经颅直流电刺激对边缘型人格障碍冲动性的影响。
- 主动刺激参数为2 mA、30分钟,作用于背外侧前额叶皮层,连续5天。
- 主要疗效指标为脑电图在气球模拟风险任务中特定诱发电位的波幅变化。
核心结论
- 本研究探讨经颅直流电刺激的安全性和效果,可能对边缘型人格障碍患者的冲动性产生显著影响,并可能有助于减少危险行为。
研究设计与样本
- 多中心、交叉、双盲研究,比较主动与伪经颅直流电刺激(2 mA,30分钟),作用于背外侧前额叶皮层,连续5天,纳入50例边缘型人格障碍患者。
主要发现
- 参与者将评估冲动性、抑郁症状和自杀风险。
- 主要疗效指标为脑电图在气球模拟风险任务中检测的特定诱发电位的波幅变化。
- 基线测量与干预后即刻、12天及30天后的评分进行比较。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Impulsivity is a core feature of borderline personality disorder (BPD) and is closely related to suicide risk and destructive and aggressive behaviors. Although transcranial direct current stimulation (tDCS) has shown its promising effects as an intervention to modulate impulsivity, no study has explored its potential regarding BPD. METHODS/DESIGN: This is a multicenter, crossover, double-blind study comparing active versus sham tDCS (2 mA, 30 min), applied over the dorsolateral prefrontal cortex for five consecutive days in 50 BPD patients. Participants will be assessed for impulsivity, depressive symptoms, and suicide risk. The main efficacy criteria on reduction of impulsivity will be the amplitude variation of one specific evoked potential detected by electroencephalography (EEG) during the balloon analogue risk task. Baseline measures will be compared to scores obtained immediately after sessions, then 12 and 30 days later. DISCUSSION: This study investigates the safety and effects of tDCS, which may have a significant impact on impulsivity in patients with BPD and may be useful to reduce risky behaviors. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03498937 . Registered on 17 April 2018.
引用
- Teti Mayer J, Nicolier M, Gabriel D, et al. Efficacy of transcranial direct current stimulation in reducing impulsivity in borderline personality disorder (TIMBER): study protocol of a randomized controlled clinical trial. Trials. 2019. PMID: 31182143. doi:10.1186/s13063-019-3427-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。